Brief: Merus Announces Publication Of An Abstract On Petosemtamab With Pembrolizumab As 1L Treatment Of R/M HNSCC

Merus NV

23/05/2024 23:50

May 23 (Reuters) - Merus NV  MRUS.O :
    * MERUS ANNOUNCES PUBLICATION OF AN ABSTRACT ON PETOSEMTAMAB
WITH
PEMBROLIZUMAB AS 1L TREATMENT OF R/M HNSCC AT THE 2024 ASCO®
ANNUAL MEETING
    * MERUS NV: FAVORABLE SAFETY PROFILE IN 26 PATIENTS ENROLLED
AS OF
ABSTRACT CUTOFF DATE, WITH NO SIGNIFICANT OVERLAPPING TOXICITIES
OBSERVED
    * MERUS NV: 60% RESPONSE RATE OBSERVED AMONG 10 EVALUABLE
PATIENTS

Source text for Eikon:  ID:nGNX1nlbms 
Further company coverage:  MRUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))